Who owns Enzon Pharmaceuticals?

Key details on Enzon Pharmaceuticals (Ticker: ENZN)

Who owns Enzon Pharmaceuticals?

Is ENZN a good stock to own? Find out who bought Enzon Pharmaceuticals, who sold Enzon Pharmaceuticals (ENZN) stock, and who holds a large position in Enzon Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
CARL C. ICAHN, INDIVIDUAL 5.90M $6.85M Dec. 31, 2013
Icahn Capital 4.72M $51.49M March 31, 2011
Baupost 4.34M $5.03M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 3.11M $3.61M Dec. 31, 2013
Artisan Partners Holdings 2.35M $23.63M June 30, 2011
Brenner West Capital Advisors 2.01M $13.98M Sept. 30, 2012
Great-West Life Assurance Company 1.44M $5.44M March 31, 2013
Iridian Asset Management 1.41M $9.81M Sept. 30, 2012
North Run Capital 1.38M $9.40M March 31, 2012
Artisan Partners Limited Partnership 1.37M $5.22M March 31, 2013
STATE STREET CORPORATION 1.30M $1.51M Dec. 31, 2013
Vanguard 1.27M $1.46M Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 1.24M $1.43M Dec. 31, 2013
First Eagle Investment Management 1.12M $7.73M June 30, 2012
BlackRock Fund Advisors 1.06M $1.23M Dec. 31, 2013
New Mountain Vantage Advisers 1.03M $7.18M Sept. 30, 2012
Brandes Investment Partners 1.02M $1.19M Dec. 31, 2013
FMR 914365 $1.06M Dec. 31, 2013
Renaissance Technologies 819984 $1.38M Sept. 30, 2013
BlackRock Advisors 789641 $915983 Dec. 31, 2013
Michael F. Price 748200 $867912 Dec. 31, 2013
UBS AG 720275 $1.21M Sept. 30, 2013

Who sold Enzon Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Perry June 30, 2011 2.01M $20.23M
TCW Dec. 31, 2010 836965 $10.19M
Paulson & Co Dec. 31, 2003 860000 $10.32M